SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-008474
Filing Date
2020-03-16
Accepted
2020-03-16 17:04:28
Documents
1
Period of Report
2020-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9320
  Complete submission text file 0000899243-20-008474.txt   11291
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Reporting) CIK: 0001700449 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 20718024

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ 44(0)20 7290 1050
Arix Bioscience Holdings Ltd (Reporting) CIK: 0001756884 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 20718023